Publications

BMJ open

Hospital-based real-world evidence in health technology assessment: insights from a scoping review of European, Australian and North American guidance and expert interviews.

31-12-2025

JCO oncology practice

Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer.

19-12-2025

Nature medicine

Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.

01-12-2025

JAMA network open

Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population.

01-12-2025

Annals of oncology : official journal of the European Society for Medical Oncology

Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial.

01-10-2025

International journal of cancer

Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective.

01-10-2025

Clinical drug investigation

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

01-08-2025

ESMO open

Financial toxicity and socioeconomic impact of cancer in Europe.

01-06-2025

PharmacoEconomics - open

Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.

01-05-2025

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer.

01-05-2025

PharmacoEconomics

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology.

01-05-2025

The Lancet. Oncology

Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer.

01-05-2025

Future oncology (London, England)

An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ.

01-12-2024

BMC cancer

Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives.

22-11-2024

Value Health.

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

26-01-2023

J Mol Diagn.

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

25-01-2023

N Engl J Med

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

08-12-2022

Hospital-based real-world evidence in health technology assessment: insights from a scoping review of European, Australian and North American guidance and expert interviews.

Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer.

Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.

Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population.

Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial.

Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective.

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Financial toxicity and socioeconomic impact of cancer in Europe.

Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.

Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer.

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology.

Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer.

An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ.

Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives.

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

This site uses cookies